The number of Americans with hepatitis C fell 16 percent to 2.7 million over almost a decade, a government survey found, just as new, more effective treatments for the chronic liver disease reach the market. The survey by the Centers for Disease Control and Prevention covers data gathered from 200…
Hepatitis C in the News Your source for hepatitis C-related news from around the web.
Not sure what to submit? Read our news guidelines first.
Hepatitis C is a disease that negatively impacts health through inflammation of the liver. The liver is the bodily organ that processes everything we put into our bodies, so it's vital we learn to keep it in the best condition possible, especially if it's struggling through hep C.
— Nearly 1 million in U.S. are infected, says Preventive Services Task Force.
(Although prices for the…) Gilead Sciences plans to license its breakthrough hepatitis C drug Sovaldi to a number of Indian generic pharmaceutical manufacturers, allowing for lower-priced sales of the medication in that developing nation, according to the company.
Practice guidelines are a fact of life in modern medicine. They provide clinicians with the best data and the latest consensus on what the data mean for the care of patients. But they are — or have been — rather slow to react to changes.
— Many aren't aware they carry the liver-destroying virus, experts say.
The death from liver cancer of Lou Reed last October helped raise awareness of the devastating toll being taken by hepatitis C in the United States. Following is a guide to the evolution of the illness and its treatment. Although HCV now kills more Americans than HIV, the hepatitis…
A revolution in treatment for the 3 million people in the U.S. chronically infected with liver-damaging hepatitis C has driven doctors to take unusual steps to speed patient access to emerging and expensive therapies. Hepatitis C is the leading cause of liver cancer and liver transplants.
A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature-resulting in a much longer period for potential transmission than was previously appreciated.
John Billeris has tried and failed four grueling rounds of treatment for his chronic hepatitis C infection over the past 15 years. He is not convinced that his fifth try - with what he jokingly calls "magic medicine" - will be the charm.